Thomas Chromecki

3.8k total citations
57 papers, 1.8k citations indexed

About

Thomas Chromecki is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Thomas Chromecki has authored 57 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Surgery, 35 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Thomas Chromecki's work include Bladder and Urothelial Cancer Treatments (41 papers), Renal cell carcinoma treatment (24 papers) and Urinary and Genital Oncology Studies (23 papers). Thomas Chromecki is often cited by papers focused on Bladder and Urothelial Cancer Treatments (41 papers), Renal cell carcinoma treatment (24 papers) and Urinary and Genital Oncology Studies (23 papers). Thomas Chromecki collaborates with scholars based in Austria, United States and Canada. Thomas Chromecki's co-authors include Richard Zigeuner, Georg C. Hutterer, Peter Rehak, Cord Langner, Karl Pummer, Shahrokh F. Shariat, Martin Pichler, Pierre I. Karakiewicz, Karin Kampel‐Kettner and K. Eugene and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Thomas Chromecki

53 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Chromecki Austria 24 1.0k 776 523 478 281 57 1.8k
Jinsoo Chung South Korea 23 634 0.6× 979 1.3× 449 0.9× 493 1.0× 325 1.2× 143 1.7k
A. Masson-Lecomte France 18 1.7k 1.6× 665 0.9× 462 0.9× 463 1.0× 154 0.5× 87 2.2k
Ilaria Lucca Switzerland 23 744 0.7× 492 0.6× 456 0.9× 258 0.5× 224 0.8× 70 1.4k
Noriomi Miyao Japan 20 768 0.8× 450 0.6× 299 0.6× 536 1.1× 201 0.7× 42 1.4k
Tomoyasu Tsushima Japan 25 673 0.7× 700 0.9× 304 0.6× 489 1.0× 136 0.5× 101 1.6k
Hervé Wallerand France 22 808 0.8× 489 0.6× 353 0.7× 666 1.4× 181 0.6× 68 1.6k
Steffen Rausch Germany 21 476 0.5× 564 0.7× 292 0.6× 497 1.0× 257 0.9× 122 1.4k
Jean‐Baptiste Lattouf Canada 24 718 0.7× 670 0.9× 267 0.5× 376 0.8× 143 0.5× 93 1.5k
R. Sylvester Belgium 21 686 0.7× 976 1.3× 637 1.2× 214 0.4× 287 1.0× 54 1.9k
Laurent Zini France 26 781 0.8× 1.1k 1.4× 175 0.3× 783 1.6× 274 1.0× 47 1.7k

Countries citing papers authored by Thomas Chromecki

Since Specialization
Citations

This map shows the geographic impact of Thomas Chromecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Chromecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Chromecki more than expected).

Fields of papers citing papers by Thomas Chromecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Chromecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Chromecki. The network helps show where Thomas Chromecki may publish in the future.

Co-authorship network of co-authors of Thomas Chromecki

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Chromecki. A scholar is included among the top collaborators of Thomas Chromecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Chromecki. Thomas Chromecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, Andreas, Jens Hansen, Michael Rink, et al.. (2015). Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma – Impact on prognosis. European Journal of Surgical Oncology. 42(3). 419–425. 26 indexed citations
2.
Meyer, Christian P., Jens Hansen, Andreas Becker, et al.. (2015). The Adoption of Nephron-Sparing Surgery in Europe - A Trend Analysis in Two Referral Centers from Austria and Germany. Urologia Internationalis. 96(3). 330–336. 17 indexed citations
3.
Pichler, Martin, Georg C. Hutterer, Thomas Chromecki, et al.. (2012). Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma. Histopathology. 62(2). 219–228. 15 indexed citations
4.
5.
Rink, Michael, Felix K.‐H. Chun, Thomas Chromecki, et al.. (2012). Das fortgeschrittene Urothelkarzinom der Harnblase beim älteren Patienten. Der Urologe. 51(6). 820–828. 13 indexed citations
6.
Pichler, Martin, Georg C. Hutterer, Thomas Chromecki, et al.. (2012). Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma. Histopathology. 62(2). 237–246. 12 indexed citations
7.
Chromecki, Thomas, Robert S. Svatek, S. Holmäng, et al.. (2011). Prognostic factors of cancer recurrence and progression in non-muscle-invasive urothelial carcinoma: A multicenter study of over 4,300 patients.. Journal of Clinical Oncology. 29(7_suppl). 249–249.
8.
Matsushita, Kazuhito, K. Eugene, Kazumasa Matsumoto, et al.. (2011). Immunohistochemical biomarkers for bladder cancer prognosis. International Journal of Urology. 18(9). 616–629. 55 indexed citations
9.
Ehdaie, Behfar, Thomas Chromecki, Richard K. Lee, et al.. (2011). Obesity Adversely Impacts Disease Specific Outcomes in Patients With Upper Tract Urothelial Carcinoma. The Journal of Urology. 186(1). 66–72. 47 indexed citations
10.
Sooriakumaran, Prasanna, Shahrokh F. Shariat, Abhishek Srivastava, et al.. (2011). 650 COMPARATIVE OUTCOME ANALYSIS OF OPEN VERSUS ROBOTIC-ASSISTED RADICAL PROSTATECTOMY MATCHED BY D'AMICO RISK CATEGORY. The Journal of Urology. 185(4S).
11.
Eugene, K., Justin M. Dubin, Himisha Beltran, et al.. (2011). Novel therapeutics for the management of castration‐resistant prostate cancer (CRPC). British Journal of Urology. 109(7). 968–985. 25 indexed citations
12.
Chromecki, Thomas, K. Eugene, Karl Pummer, et al.. (2011). Prognostic value of insulin‐like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy. British Journal of Urology. 110(1). 63–68. 20 indexed citations
13.
14.
Shariat, Shahrokh F., Caroline Savage, Thomas Chromecki, et al.. (2011). Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle‐invasive bladder cancer and negative cytology. Cancer. 117(13). 2892–2897. 41 indexed citations
15.
Martínez‐Salamanca, Juan Ignacio, Shahrokh F. Shariat, Joaquı́n Carballido, et al.. (2011). Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. British Journal of Urology. 109(8). 1155–1161. 33 indexed citations
16.
Marszalek, Martin, Thomas Chromecki, Badereddin Mohamad Al–Ali, et al.. (2010). Laparoscopic Partial Nephrectomy: A Matched-pair Comparison of the Transperitoneal Versus the Retroperitoneal Approach. Urology. 77(1). 109–113. 45 indexed citations
17.
Pristauz, Gunda, Farid Moinfar, Thomas Chromecki, et al.. (2009). Inflammatory myofibroblastic tumour of the urinary bladder mimicking recurrent uterine carcinosarcoma. Histopathology. 54(4). 490–493. 3 indexed citations
18.
Leibl, Sebastian, Richard Zigeuner, Georg C. Hutterer, et al.. (2008). EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology. Apmis. 116(1). 27–32. 31 indexed citations
19.
Zigeuner, Richard, Georg C. Hutterer, Thomas Chromecki, Peter Rehak, & Cord Langner. (2006). Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. British Journal of Urology. 98(6). 1181–1186. 115 indexed citations
20.
Zigeuner, Richard, Georg C. Hutterer, Thomas Chromecki, Peter Rehak, & Cord Langner. (2006). BIOLOGICAL SIGNIFICANCE OF SQUAMOUS AND GLANDULAR DIFFERENTIATION IN UROTHELIAL CELL CARCINOMA OF THE UPPER URINARY TRACT. European Urology Supplements. 5(2). 136–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinsoo Chung Breakdown of academic impact, for papers by A. Masson-Lecomte Breakdown of academic impact, for papers by Ilaria Lucca Breakdown of academic impact, for papers by Noriomi Miyao Breakdown of academic impact, for papers by Tomoyasu Tsushima Breakdown of academic impact, for papers by Hervé Wallerand Breakdown of academic impact, for papers by Steffen Rausch Breakdown of academic impact, for papers by Jean‐Baptiste Lattouf Breakdown of academic impact, for papers by R. Sylvester Breakdown of academic impact, for papers by Laurent Zini
Rankless by CCL
2026